leisure time -WSS

leisure time

author：comprehensive 2025-08-12 09:12:54 - browse：4

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Why you get paid to donate plasma but not blood

hotspot

WSS

Flagship, Pfizer team up in deal worth up to $7 billion

Johnson & Johnson sues to stop Medicare negotiation

Johnson & Johnson sues to stop Medicare negotiation

What we know about the American soldier detained in North Korea

Britney Spears to release memoir, 'The Woman In Me,' later this year

ER docs worry over extreme heat as a 'mass casualty event'

entertainment

leisure time

explore

Medicare details structure of new drug price negotiation program

Lack of darker skin in textbooks, journals harms patients of color

Heart attack and stroke risk calculators need revising

The debate over Covid

Medicare details structure of new drug price negotiation program

Study: Hearing aids may slow cognitive decline in those at risk

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Study: Hearing aids may slow cognitive decline in those at risk

23andMe had bad news about my health. I wish a person had delivered it

EU fines Illumina $475 million over Grail acquisition

leisure time

The debate over Covid

Manchin plays down potential 3rd

A strong 6.5

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

EU fines Illumina $475 million over Grail acquisition

Women's World Cup brings attention to abuse in soccer

hotspot

hotspot

knowledge

hotspot